Phase 2 study of nilotinib as third-line
β
Akira Sawaki; Toshirou Nishida; Toshihiko Doi; Yasuhide Yamada; Yoshito Komatsu;
π
Article
π
2011
π
John Wiley and Sons
π
English
β 263 KB